Lipocine Inc.·4

Jun 4, 4:05 PM ET

Ono Richard Dana 4

4 · Lipocine Inc. · Filed Jun 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Lipocine (LPCN) Director Richard Ono Receives 1,764-Share Award

What Happened
Richard Ono, a director of Lipocine Inc. (LPCN), was granted 1,764 shares as a derivative award on 2026-06-03. The award is recorded at $2.19 per share for a total reported value of $3,863. This was an acquisition/award (transaction code A), not a sale.

Key Details

  • Transaction date and price: 2026-06-03 at $2.19 per share (total $3,863).
  • Shares acquired: 1,764 derivative shares (award).
  • Vesting: Footnote F1 — 100% vests one year from the grant date (i.e., fully vesting 2027-06-03).
  • Shares owned after transaction: Not specified in the provided data.
  • Filing timeliness: Report filed 2026-06-04 for a 2026-06-03 transaction (filed promptly, not marked late).
  • Other notes: Report lists the grant as a derivative award (commonly RSUs or similar); no 10b5-1 plan, tax withholding, or cashless-sale details provided.

Context
This was a small-value director award that vests in one year. Derivative grants align insiders with shareholder value over the vesting period but do not indicate an immediate purchase or sale of stock.

Insider Transaction Report

Form 4
Period: 2026-06-03
Transactions
  • Award

    Common Stock (Right to Buy)

    [F1]
    2026-06-03$2.19/sh+1,764$3,86313,290 total
    Exercise: $2.19From: 2027-06-03Exp: 2036-06-03Common Stock (1,764 underlying)
Footnotes (1)
  • [F1]100% vesting one year from date of grant.
Signature
/s/ Richard Dana Ono|2026-06-04

Documents

1 file
  • 4
    ownership.xmlPrimary